Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: AbbVie

Study finds headache drug could prevent overuse of acute migraine medications

Study finds headache drug could prevent overuse of acute migraine medications
p p Read More

Chronic migraine is a neurological condition estimated to affect up to 2.2% of people globally

July 3, 2024 AbbVie, acute migraine, atogepant, chronic migraine, chronic migriane, King’s College London, News, Qulipta

AbbVie’s Produodopa approved by SMC to treat Parkinson’s disease patients in Scotland

The progressive neurological disorder affects approximately 12,400 people in Scotland

March 13, 2024 AbbVie, foslevodopa-foscarbidopa, Neurological disorders, News, Parkinson's disease, Produodopa, Scottish Medicines Consortium

AbbVie’s Skyrizi shows promise as personalised treatment for psoriasis

The immunosuppressant reduced inflammation in patients with the skin condition after three days

February 23, 2024 AbbVie, chronic skin diseases, dermatological diseases, King’s College London, News, psoriasis, risankizumab, Skyrizi
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy